Abstract
The implantation of percutaneous balloon expandable valves in native or patched right ventricular outflow tracts (nRVOT) is a challenging technique due to the diversity of anatomies and shapes, the large sizes, and the distensibility of the nRVOT, for which specific techniques have been developed. We present a single center experience with balloon expandable percutaneous pulmonary valves in nRVOT, describing the techniques used, complications observed, and a short-mid term follow-up.. This is a single center descriptive study of patients who underwent a percutaneous pulmonary valve implantation in a nRVOT with a balloon expandable pulmonary valve in our center between September 2012 and June 2022.. We implanted successfully 45 valves in 46 patients (20 Sapien and 25 Melody). Tetralogy of Fallot or pulmonary atresia with VSD were the main congenital heart disease (n = 32). All were pre-stented, 18 in a one step procedure. We used a Dryseal sheath in 13/21 Sapien. In 6 patients we used the anchoring technique, 5 with a very large nRVOT and one pyramidal nRVOT. In the 3.5 year follow-up 7 patients developed endocarditis and 3 required a valve redilation, no fractures were observed. PPVI of native RVOT with balloon expandable valves is feasible in a number of selected anatomies, including large or pyramidal nRVOT, using specific techniques, (presenting, LPA anchoring).
Similar content being viewed by others
Abbreviations
- RVOT:
-
Right ventricular outflow tract
- nRVOT:
-
Native or patched right ventricular outflow tract
- PPVI:
-
Percutaneous pulmonary valve implantation
- LPA:
-
Left pulmonary artery
- RPA:
-
Right pulmonary artery
- CHD:
-
Congenital heart disease
- TOF:
-
Tetralogy of Fallot
- PA:
-
Pulmonary atresia
- VSD:
-
Ventricular septal defect
- PS:
-
Pulmonary stenosis
- DORV:
-
Double-outlet right ventricle
- TGA:
-
Transposition of the great arteries
References
Bonhoeffer P, Boudjemline Y, Saliba Z, Merckx J, Aggoun Y, Bonnet D, Acar P, Le Bidois J, Sidi D, Kachaner J (2000) Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. https://doi.org/10.1016/S0140-6736(00)02844-0]
Boone RH, Webb JG, Horlick E, Benson L, Cao QL, Nadeem N, Kiess M, Hijazi ZM (2010) Transcatheter pulmonary valve implantation using the Edwards SAPIEN transcatheter heart valve. Catheter CardiovascInterv 75:286–294. https://doi.org/10.1002/ccd.22250]
Esmaeili A, Khalil M, Behnke-Hall K, Gonzalez YGonzalez MB, Kerst G, Fichtlscherer S, Akintuerk H, Schranz D (2019) Percutaneous pulmonary valve implantation (PPVI) in non-obstructive right ventricular outflow tract: limitations and mid-term outcomes. Transl Pediatr. 8(2):107–113. https://doi.org/10.21037/tp.2019.04.02
Martin MH, Meadows J, McElhinney DB, Goldstein BH, Bergersen L, Qureshi AM, Shahanavaz S, Aboulhosn J, Berman D, Peng L, Gillespie M, Armstrong A, Weng C, Minich LL, Gray RG (2018) Safety and feasibility of melody transcatheter pulmonary valve replacement in the native right ventricular outflow tract: a multicenter pediatric heart network scholar study. JACC Cardiovasc Interv 11(16):1642–1650. https://doi.org/10.1016/j.jcin.2018.05.051. (Epub 2018 Aug 1 PMID: 30077685)
Alvarez-Fuente M, Garrido-Lestache E, Fernandez-Pineda L, Romera B, Sánchez I, Centella T, Abelleira C, Villagrá S, Tamariz R, Barrios E, Lamas MJ, Gomez R, Del Cerro MJ (2016) Timing of pulmonary valve replacement: how much can the right ventricle dilate before it looses its remodeling potential? Pediatr Cardiol 37(3):601–605. https://doi.org/10.1007/s00246-015-1320-4. (Epub 2015 Dec 21 PMID: 26687177)
Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller GP, Lung B, Kluin J, Lang IM, Meijboom F, Moons P, Mulder BJM, Oechslin E, Roos-Hesselink JW, Schwerzmann M, Sondergaard L, Zeppenfeld K, ESC Scientific Document Group (2021) ESC Guidelines for the management of adult congenital heart disease. Eur Heart J 42(6):563–645. https://doi.org/10.1093/eurheartj/ehaa554. (PMID: 32860028)
Malekzadeh-Milani S, ladoucer M, Cohen S, Iserin L, Boudjemline Y (2014) Results of transcatheter pulmonary valvulation in native or patched right ventricular outflow tracts. Arch Cardiovasc Dis 07:592–8
Karsenty C, Malekzadeh-Milani S, Fraisse A, Gewillig M, Bonnet D, Aldebert P, Ovaert C, Bouvaist H, Kempny A, Houeijeh A, Petit J, Hascoet S (2020) Right ventricular outflow tract prestenting with AndraStent XXL before percutaneous pulmonary valve implantation. Arch Cardiovasc Dis 113(2):113–120. https://doi.org/10.1016/j.acvd.2019.12.004. (Epub 2020 Feb 18 PMID: 32081640)
Georgiev S, Tanase D, Ewert P, Meierhofer C, Hager A, von Ohain JP, Eicken A (2018) Percutaneous pulmonary valve implantation in patients with dysfunction of a “native” right ventricular outflow tract—Mid-term results. Int J Cardiol 1(258):31–35. https://doi.org/10.1016/j.ijcard.2017.11.091. (PMID: 29544952)
Kenny D, Morgan GJ, Murphy M, AlAlwi K, Giugno L, Zablah J, Carminati M, Walsh K (2019) Use of 65 cm large caliber Dryseal sheaths to facilitate delivery of the Edwards SAPIEN valve to dysfunctional right ventricular outflow tracts. Catheter Cardiovasc Interv 94(3):409–413. https://doi.org/10.1002/ccd.28409. (Epub 2019 Aug 13 PMID: 31408262)
Couture EL, Labbé BM, DeLarochellière R, Rodés-Cabau J, Paradis J-M (2016) Stuck leaflet after transcatheter aortic valve replacement with a SAPIEN-3 Valve: new valve, old complication. JACC Cardiovasc Interv 9:e133–e135
Güzeltaş A, Tanıdır IC, Gökalp S, Topkarcı MA, Şahin M, Ergül Y (2021) Implantation of the Edwards SAPIEN XT and SAPIEN 3 valves for pulmonary position in enlarged native right ventricular outflow tract. Anatol J Cardiol 25(2):96–103. https://doi.org/10.14744/AnatolJCardiol.2020.46024.PMID:33583816;PMCID:PMC8114652
Giugno L, Faccini A, Carminati M (2020) Percutaneous pulmonary valve implantation. Korean Circ J 50(4):302–316. https://doi.org/10.4070/kcj.2019.0291.PMID:32157831;PMCID:PMC7067602
Ansari MM, Cardoso R, Garcia D, Sandhu S, Horlick E, Brinster D, Martucci G, Piazza N (2015) Percutaneous pulmonary valve implantation: present status and evolving future. J Am Coll Cardiol 66(20):2246–2255. https://doi.org/10.1016/j.jacc.2015.09.055. (PMID: 26564602)
Morgan GJ, Sadeghi S, Salem MM, Wilson N, Kay J, Roth-man A et al (2019) SAPIEN valve for percutaneous transcatheterpulmonary valve replacement without ‘“pre-stenting”’: amulti-institutional experience. Catheter Cardiovasc Interv 93:324–329
Sinha S, Aboulhosn J, Asnes J, Bocks M, Zahn E, Goldstein BH et al (2019) Initial results from the off-label use of the SAPIEN S3 valve for percutaneous transcatheter pulmonary valve replacement: a multi-institutional experience. Catheter Cardiovasc Interv 93(455–63):29
Cardoso R, Ansar M, Garcia D et al (2016) Prestenting for prevention of melody valve fractures: a systematic review and meta-analysis. Catheter Cardiovasc Interv. 87(3):534–539
Author information
Authors and Affiliations
Contributions
MAF and MJC wrote the main manuscript and prepared the figures. All authors collected the data and reviewed the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Álvarez-Fuente, M., Toledano, M., Garrido-Lestache, E. et al. Balloon-Expandable Pulmonary Valves for Patched or Native Right Ventricular Outflow Tracts. Pediatr Cardiol 44, 1285–1292 (2023). https://doi.org/10.1007/s00246-023-03173-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-023-03173-2